PIDTC: Investigating Outcomes of Allogeneic Hematopoietic Cell Transplantation in Chronic Granulomatous Disease
Feb 23, 2024 ·
1m 43s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood on December 14, 2023, titled "Genotype, oxidase status,...
show more
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood on December 14, 2023, titled "Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD."
Read the paper here: https://ashpublications.org/blood/article-abstract/142/24/2105/497415/Genotype-oxidase-status-and-preceding-infection-or?redirectedFrom=fulltext
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
show less
Read the paper here: https://ashpublications.org/blood/article-abstract/142/24/2105/497415/Genotype-oxidase-status-and-preceding-infection-or?redirectedFrom=fulltext
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
